Litigation Details for Allergan USA, Inc. v. Sun Pharmaceutical Industries Ltd. (D. Del. 2020)
✉ Email this page to a colleague
Allergan USA, Inc. v. Sun Pharmaceutical Industries Ltd. (D. Del. 2020)
Docket | ⤷ Sign Up | Date Filed | 2020-10-29 |
Court | District Court, D. Delaware | Date Terminated | |
Cause | 35:271 Patent Infringement | Assigned To | |
Jury Demand | None | Referred To | |
Patents | 10,188,632; 7,741,356; 9,675,587 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Allergan USA, Inc. v. Sun Pharmaceutical Industries Ltd.
Details for Allergan USA, Inc. v. Sun Pharmaceutical Industries Ltd. (D. Del. 2020)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2020-10-29 | 1 | Complaint | U.S. Patent No. 9,675,587 (“the ’587 patent”) and U.S. Patent No. 10,188,632 (“the ’632 patent”) were…Sun of U.S. Patent No. 7,741,356 (“the ’356 patent”). This action is based upon the Patent Laws of the… THE PATENTS 11. On June 22, 2010, the ’356 patent, titled “Compounds As …’356 patent on September 23, 2014 and May 12, 2020. Janssen is the sole owner of the ’356 patent. Allergan…IV) allegations with respect to the ’587 patent and ’632 patent no earlier than July 31, 2019, and timely | External link to document |
2020-10-29 | 4 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,741,356 B2. (myr) (Entered:… 29 October 2020 1:20-cv-01479 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |